Hydrogel delivery of erythropoietin to the brain for endogenous stem cell stimulation after stroke injury
Source abstract
Abstract
Drug delivery to the brain is challenging because systemic delivery requires high doses to achieve diffusion across the blood-brain barrier and often results in systemic toxicity. Intracerebroventricular implantation of a minipump/catheter system provides local delivery, yet results in brain tissue damage and can be prone to infection. An alternate local delivery strategy, epi-cortical delivery, releases the biomolecule directly to the brain while causing minimal tissue disruption. We pursued this strategy with a hyaluronan/methyl cellulose (HAMC) hydrogel for the local release of erythropoietin to induce endogenous neural stem and progenitor cells of the subventricular zone to promote repair after stroke injury in the mouse brain. Erythropoeitin promotes neurogenesis when delivered intraventricularly, thereby making it an ideal biomolecule with which to test this new epi-cortical delivery strategy. We investigated HAMC in terms of the host tissue response and the diffusion of erythropoeitin therefrom in the stroke-injured brain for neural repair. Erythropoietin delivered from HAMC at 4 and 11 days post-stroke resulted in attenuated inflammatory response, reduced stroke cavity size, increased number of both neurons in the peri-infarct region and migratory neuroblasts in the subventricular zone, and decreased apoptosis in both the subventricular zone and the injured cortex. We demonstrate that HAMC-mediated epi-cortical administration is promising for minimally invasive delivery of erythropoeitin to the brain.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nerve injury and regeneration · Neurogenesis and neuroplasticity mechanisms · Erythropoietin and Anemia Treatment
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (54)
Show source-provided references
1. The stroke data-bank - design, methods, and baseline characteristics10.1161/01.STR.19.5.547 ↗
2. Prospective-study of endogenous-tissue plasminogen-activator and risk of stroke10.1016/S0140-6736(94)90064-7 ↗
3. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain10.1016/S0092-8674(00)80783-7 ↗
4. Erythropoietin: novel approaches to neuroprotection in human brain disease10.1023/B:MEBR.0000043969.96895.3c ↗
5. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats10.1161/01.STR.0000132196.49028.a4 ↗
6. Recombinant human erythropoietin: approaches to neuroprotection and neuroregeneration in schizophrenia
7. A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery10.1523/JNEUROSCI.4480-05.2006 ↗
8. Erythropoietin therapy for acute stroke is both safe and beneficial10.1007/BF03402029 ↗
9. Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells10.1523/JNEUROSCI.21-24-09733.2001 ↗
10. Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS10.3109/10611860903318134 ↗
11. Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment10.1136/ard.2005.041673 ↗
12. Blood-pressure, erythropoietin and autonomic function
13. Evaluation of symptom relief, nasal airflow, nasal cytology, and acceptability of two formulations of flunisolide nasal spray in patients with perennial allergic rhinitis
14. Intranasal erythropoietin therapy in nervous system disorders10.1517/17425247.2011.540236 ↗
15. Drug delivery to the central nervous system: a review
16. Strategies for drug delivery through the blood-brain-barrier10.1016/0197-4580(89)90160-7 ↗
17. Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord10.1016/j.biomaterials.2005.11.015 ↗
18. Controlled epi-cortical delivery of epidermal growth factor for the stimulation of endogenous neural stem cell proliferation in stroke-injured brain10.1016/j.biomaterials.2011.04.032 ↗
19. A new paradigm for local and sustained release of therapeutic molecules to the injured spinal cord for neuroprotection and tissue repair10.1089/ten.tea.2007.0349 ↗
20. Drugs released from polymers - diffusion and elimination in brain-tissue10.1016/0009-2509(91)80036-X ↗
21. Multiphoton microscopy guides neurotrophin modification with poly(ethylene glycol) to enhance interstitial diffusion10.1038/nmat1159 ↗
22. Diffusion of epidermal growth factor in rat brain extracellular space measured by integrative optical imaging10.1152/jn.00352.2004 ↗
23. Transport of epidermal growth factor in the stroke-injured brain10.1016/j.jconrel.2010.10.022 ↗
24. A potential role for erythropoietin in focal permanent cerebral ischemia in mice10.1097/00004647-199906000-00007 ↗
25. Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain10.1007/s004010000297 ↗
26. Sensorimotor behavioral effects of endothelin-1 induced small cortical infarcts in C57BL/6 mice10.1016/j.jneumeth.2009.04.009 ↗
27. Erythropoietin and erythropoietin receptor in the developing human central nervous system10.1203/00006450-199801000-00007 ↗
28. Evidence of receptor-mediated elimination of erythropoietin by analysis of erythropoietin receptor mRNA expression in bone marrow and erythropoietin clearance during anemia10.1124/jpet.109.163568 ↗
29. Transient expression of doublecortin during adult neurogenesis10.1002/cne.10874 ↗
30. The doublecortin-expressing population in the developing and adult brain contains multipotential precursors in addition to neuronal-lineage cells10.1523/JNEUROSCI.5060-06.2007 ↗
31. Inflammation and hyaluronic acid10.1089/act.2008.14201 ↗
32. Inhibition of leukocyte locomotion by hyaluronic-acid10.1242/jcs.48.1.315 ↗
33. The effect of hyaluronan on interleukin-1-alpha-induced prostaglandin-E2 production in human osteoarthritic synovial cells10.1007/BF01987905 ↗
34. The repair of brain lesion by implantation of hyaluronic acid hydrogels modified with laminin10.1016/j.jneumeth.2005.04.016 ↗
35. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells10.1189/jlb.1109766 ↗
36. Induction of CD44 expression in stab wounds of the brain: long term persistence of CD44 expression10.1054/jocn.1999.0187 ↗
37. Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice10.1038/sj.jcbfm.9600417 ↗
38. Passage of erythropoietic agents across the blood-brain barrier: a comparison of human and murine erythropoietin and the analog darbepoetin alfa10.1016/j.ejphar.2004.10.035 ↗
39. Erythropoietin gene expression in human, monkey and murine brain10.1111/j.1460-9568.1996.tb01252.x ↗
40. Pharmacokinetic aspects of biotechnology products10.1002/jps.20125 ↗
41. Modulation of the postischemic immune response to improve stroke outcome10.1161/STROKEAHA.110.592881 ↗
42. Timing the microenvironment: the effect of inflammatory cues on neural stem cell properties and cell-mediated potential for recovery and repair after spinal cord injury
43. Influence of the pro-inflammatory cytokines on P-glycoprotein expression and functionality
44. Erythropoietin as neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research
45. Analysis of neuronal proliferation, migration and differentiation in the postnatal brain using equine infectious anemia virus-based lentiviral vectors10.1038/gt.2009.58 ↗
46. Erythropoietin promotes spinal cord-derived neural progenitor cell proliferation by regulating cell cycle10.1016/j.neuroscience.2010.02.007 ↗
47. Neurogenin 1 mediates erythropoietin enhanced differentiation of adult neural progenitor cells10.1038/sj.jcbfm.9600215 ↗
48. Effects of erythropoietin administration on cerebral metabolism and exercise capacity in men10.1152/japplphysiol.00234.2010 ↗
49. An injectable drug delivery platform for sustained combination therapy10.1016/j.jconrel.2009.05.009 ↗
50. Growth factor-stimulated generation of new cortical tissue and functional recovery after stroke damage to the motor cortex of rats10.1038/sj.jcbfm.9600402 ↗
51. Intranasal delivery of erythropoietin plus insulin-like growth factor-I for acute neuroprotection in stroke
52. Poly(ethylene glycol) modification enhances penetration of fibroblast growth factor 2 to injured spinal cord tissue from an intrathecal delivery system10.1016/j.jconrel.2010.01.029 ↗
53. Intrathecal drug delivery strategy is safe and efficacious for localized delivery to the spinal cord10.1016/S0079-6123(06)61027-3 ↗
54. Accelerated release of a sparingly soluble drug from an injectable hyaluronan-methylcellulose hydrogel10.1016/j.jconrel.2009.05.025 ↗